Sat, Feb 28, 2015, 6:12 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Talon Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Feb 8, 2010 8:04 PM Flag

    Any update on conf. presentation ?

    Nothing new. He makes a reasonable case for why Marquibo should be approvable - good efficacy and safety in 2nd relapse population and a history by the FDA of similar approvals (i.e. small single-agent studies in difficult-to-treat settings). But regardless of whether you believe the story, the company doesn't have the cash to get them to approval, which would be mid-next year. And since he offers hints of other funding mechanism (e.g. partnering Medadione or one of the other drugs), the only conclusion you are left with is a ultra-dilutive offering, so why would you buy it now. For those of us already long, you can only hope that they sell the company or partner something.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.